Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology?
Ayhan, Murat, Turan, Nedim, Köstek, Osman, Tufan, Gülnihal, TataroÄlu Ãzyükseler, Deniz, Odabas, Hatice, Sakin, Abdullah, Turan, Merve, Sürmeli, Heves, Yıldırım, Mahmut EmreJournal:
Current Problems in Cancer
DOI:
10.1016/j.currproblcancer.2020.100670
Date:
October, 2020
File:
PDF, 732 KB
2020
File converter
More search results
More benefits 
